295 related articles for article (PubMed ID: 20207774)
1. Improved immunogenicity of biodegradable polymer particles entrapped rotavirus vaccine.
Nayak B; Ray AR; Panda AK; Ray P
J Biomater Appl; 2011 Jan; 25(5):469-96. PubMed ID: 20207774
[TBL] [Abstract][Full Text] [Related]
2. Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination.
Nayak B; Panda AK; Ray P; Ray AR
J Microencapsul; 2009 Mar; 26(2):154-65. PubMed ID: 18608800
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes.
Puras G; Salvador A; Igartua M; Hernández RM; Pedraz JL
Eur J Pharm Sci; 2011 Oct; 44(3):200-6. PubMed ID: 21820509
[TBL] [Abstract][Full Text] [Related]
4. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
[TBL] [Abstract][Full Text] [Related]
5. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
[TBL] [Abstract][Full Text] [Related]
6. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.
Katare YK; Muthukumaran T; Panda AK
Int J Pharm; 2005 Sep; 301(1-2):149-60. PubMed ID: 16023313
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
8. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.
Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444
[TBL] [Abstract][Full Text] [Related]
9. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
Singh J; Pandit S; Bramwell VW; Alpar HO
Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
[TBL] [Abstract][Full Text] [Related]
10. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.
Mata E; Igartua M; Patarroyo ME; Pedraz JL; Hernández RM
Eur J Pharm Sci; 2011 Sep; 44(1-2):32-40. PubMed ID: 21699977
[TBL] [Abstract][Full Text] [Related]
11. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.
Agnello D; Hervé CA; Lavaux A; Darniot M; Guillon P; Charpilienne A; Pothier P
J Virol; 2006 Apr; 80(8):3823-32. PubMed ID: 16571799
[TBL] [Abstract][Full Text] [Related]
12. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit.
Mohaghegh M; Tafaghodi M
Pharm Dev Technol; 2011 Feb; 16(1):36-43. PubMed ID: 20082579
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice.
Chattaraj SC; Rathinavelu A; Das SK
J Control Release; 1999 Mar; 58(2):223-32. PubMed ID: 10053195
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of parenteral depot insulin formulation using PLGA and PLA microparticles.
Naha PC; Kanchan V; Panda AK
J Biomater Appl; 2009 Nov; 24(4):309-25. PubMed ID: 18987018
[TBL] [Abstract][Full Text] [Related]
15. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants.
Appaiahgari MB; Glass R; Singh S; Taneja S; Rongsen-Chandola T; Bhandari N; Mishra S; Vrati S
Vaccine; 2014 Feb; 32(6):651-6. PubMed ID: 24374502
[TBL] [Abstract][Full Text] [Related]
16. PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).
Fredriksen BN; Grip J
Vaccine; 2012 Jan; 30(3):656-67. PubMed ID: 22100638
[TBL] [Abstract][Full Text] [Related]
17. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles.
Yeh MK; Liu YT; Chen JL; Chiang CH
J Control Release; 2002 Aug; 82(2-3):237-47. PubMed ID: 12175740
[TBL] [Abstract][Full Text] [Related]
18. Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine.
Sturesson C; Degling Wikingsson L
J Control Release; 2000 Sep; 68(3):441-50. PubMed ID: 10974398
[TBL] [Abstract][Full Text] [Related]
19. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
Liu X; Yang T; Sun QM; Sun MS
Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
[TBL] [Abstract][Full Text] [Related]
20. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles.
Katare YK; Panda AK
Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
